Our worker-centric trade policy is a key part of the Biden-Harris administration's effort to Build Back Better.
Katherine Tai
The Public Record
Katherine Chi Tai is an American attorney and trade policy expert currently serving as the United States Trade Representative since March 2021. She is notable for being the first Asian American and the first woman of color to hold this position. In her role, Tai has focused on addressing trade issues and promoting fair trade practices, particularly in relation to China and other global partners. Her work emphasizes the importance of labor rights and environmental standards in trade agreements.
The administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports a waiver of those protections for COVID-19 vaccines.
It has been an unfair competitive advantage that we need to level the playing field for.
I know what your views are on this, and I look forward to working with you on other tools that we can use.
I think that we need to be engaging with the rest of the world--and certainly in this part of the world--from a position of strength.
I commit to consulting with this committee; that is why I am here, that is why I will be here when you ask me to come.
At the request and recommendation of Senator Portman, I have committed to doing a top-to-bottom review of our China trade policy.
USTR specifically has been charged with making sure that efforts that we take do not undermine labor protections in those regions.
The administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines.
This is a global health crisis and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures.
the administration believes strongly in intellectual property protections. But in service of ending this pandemic supports the waiver of those protections for COVID-19 vaccines.
We still have a lot of work ahead. That includes making the vaccine widely available and addressing the global inequity in vaccine access.





